Why Epizyme Inc.'s Shares Are Skyrocketing Today

What happened Shares of Epizyme NASDAQ EPZM 160 rallied sharply higher following data showing its lead drug candidate tazemetost delivered solid response rates in follicular lymphoma Shares finished trading today up 17 4 So what Tazemetostat won fast track status